Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Rubenstein, L M

Economic and health-related quality of life considerations of new therapies in Parkinson's disease. [electronic resource] - PharmacoEconomics 2001 - 729-52 p. digital

Publication Type: Journal Article; Review

1170-7690

10.2165/00019053-200119070-00003 doi


Cost of Illness
Cost-Benefit Analysis
Health Care Costs
Health Status
Humans
Parkinson Disease--drug therapy
Quality of Life